No previous study has indicated the diagnostic value of BCL2L11, NAGS, HDHD3 and RMND1 in NAFLD, so we reported for the first time that the four MRGs may serve as promising diagnostic biomarkers for NAFLD, whether alone or in combination. This evidence concerns the gene HDHD3 and metabolic dysfunction-associated steatotic liver disease.